Skip to main content
Centessa Pharmaceuticals plc logo

Centessa Pharmaceuticals plc — Investor Relations & Filings

Ticker · CNTA ISIN · US1523091007 LEI · 213800GIDAARDSKOI827 US Manufacturing
Filings indexed 547 across all filing types
Latest filing 2026-04-29 Annual Report
Country GB United Kingdom
Listing US CNTA

About Centessa Pharmaceuticals plc

https://www.centessa.com/

Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that utilizes a Research & Development innovation engine to discover and develop transformational medicines for patients. The company employs a data-driven approach to advance its portfolio of innovative assets. A key program in its pipeline is the development of potential best-in-class, orally administered orexin receptor 2 (OX2R) agonists for the treatment of sleep-wake disorders. Centessa's broader therapeutic focus often includes rare diseases and other areas with significant unmet medical needs.

Recent filings

Filing Released Lang Actions
ARS - Centessa Pharmaceuticals plc (0001847903) (Filer)
Annual Report
2026-04-29 English
DEF 14A - Centessa Pharmaceuticals plc (0001847903) (Filer)
Proxy Solicitation & Information Statement
2026-04-29 English
S-8 - Centessa Pharmaceuticals plc (0001847903) (Filer)
Registration Form
2026-03-31 English
8-K - Centessa Pharmaceuticals plc (0001847903) (Filer)
Regulatory Filings
2026-03-31 English
DFAN14A - Centessa Pharmaceuticals plc (0001847903) (Subject)
Proxy Solicitation & Information Statement
2026-03-31 English
4 - Centessa Pharmaceuticals plc (0001847903) (Issuer)
Director's Dealing
2026-03-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.